NPPA fixes price of 39 drug formulation packs

Published On 2015-07-16 11:03 GMT | Update On 2015-07-16 11:03 GMT

NEW DELHI: National drug price regulator NPPA is on the rally. After fixing prices of a number of drug formations of around 30 drug formulation packs, including those for TB, Diabates, Asthma and many antibiotics, on 13/07/2015, it has fixed the prices of 39 formulation packs. This time drugs include those used to treat diseases such as diabetes, infections, digestive disorders and pain among others.As per the notification the prices of formulations including Ciprofloxacin Hydrochloride, Cefotaxime, Paracetamol, Domperidone and Metformin+Glimepiride has been fixed.

At present, the government caps prices of essential drugs based on the simple average of all medicines in a particular therapeutic segment with sales of more than 1 per cent.

Besides, the government regulates prices of all other medicines and companies are allowed to hike prices of such drugs by only up to 10 per cent in a year.

The government had notified DPCO, 2013, which covers 680 formulations, with effect from May 15, 2014, replacing the 1995 order that regulated prices of only 74 bulk drugs.

Established in 1997, NPPA has been entrusted with the task of fixation/revision of prices of pharmaceutical products (bulk drugs and formulations), enforcement of provisions of the Drugs (Prices Control) Order and monitoring of prices of controlled and decontrolled drugs in the country.

You can checkout the entire list of drug formulations so checked in the linked below

http://www.nppaindia.nic.in/wh-new-2015/wh-new-46-2015.html

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She is a member of the Association of Healthcare Journalists. She can be contacted at meghna@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

NPPA fixes price of 39 drug formulation packs

Similar News

Lyme disease confirmed in Himachal Pradesh; 17 test positive

Swasth Nari Sashakt Parivar Abhiyaan concludes, benefits over 6.5 crore women

Jharkhand HC directs Govt to frame HIV guidelines for prison inmates

Bhopal Gas Tragedy: SC issues contempt notices to Health Ministry, ICMR over non-compliance of orders on medical care

Chhattisgarh NHM employees end strike after Government Talks

India conferred with Bloomberg Philanthropies Global Tobacco Control Award

LIC eyes entry into health insurance space by month end

Meerut doctor, 3 Touts arrested for illegal sex determination test